Total Payments
$67,062
2024 Payments
$45,574
Companies
32
Transactions
1,371
Medicare Patients
5,131
Medicare Billing
$4.4M
Payment Breakdown by Category
Other$35,440 (52.8%)
Food & Beverage$25,475 (38.0%)
Travel$4,323 (6.4%)
Consulting$1,562 (2.3%)
Education$261.62 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,440 | 15 | 52.8% |
| Food and Beverage | $25,475 | 1,326 | 38.0% |
| Travel and Lodging | $4,323 | 16 | 6.4% |
| Consulting Fee | $1,562 | 5 | 2.3% |
| Education | $261.62 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $36,347 | 317 | $0 (2024) |
| ABBVIE INC. | $10,159 | 182 | $0 (2024) |
| Amgen Inc. | $3,803 | 158 | $0 (2024) |
| UCB, Inc. | $2,338 | 95 | $0 (2024) |
| GENZYME CORPORATION | $1,415 | 55 | $0 (2024) |
| PFIZER INC. | $1,343 | 68 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,309 | 7 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $1,308 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,302 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,120 | 54 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,574 | 275 | Janssen Biotech, Inc. ($33,691) |
| 2023 | $4,990 | 240 | Janssen Biotech, Inc. ($961.24) |
| 2022 | $3,289 | 214 | Janssen Biotech, Inc. ($671.43) |
| 2021 | $3,262 | 150 | Janssen Biotech, Inc. ($621.84) |
| 2020 | $1,808 | 90 | Janssen Biotech, Inc. ($319.26) |
| 2019 | $3,001 | 164 | PFIZER INC. ($427.04) |
| 2018 | $3,166 | 139 | Celgene Corporation ($360.41) |
| 2017 | $1,972 | 99 | Amgen Inc. ($436.82) |
All Payment Transactions
1,371 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| 12/19/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Rheumatology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 12/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Immunology | ||||||
| 12/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | Cash or cash equivalent | $30.15 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | Cash or cash equivalent | $11.08 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $118.93 | General |
| 11/16/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,780.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | In-kind items and services | $869.76 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $121.20 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,260 | 139,163 | $4.7M | $1.2M |
| 2022 | 22 | 1,352 | 105,609 | $3.7M | $1.0M |
| 2021 | 23 | 1,310 | 101,404 | $3.6M | $1.1M |
| 2020 | 22 | 1,209 | 77,819 | $3.0M | $1.0M |
Total Patients
5,131
Total Services
423,995
Medicare Billing
$4.4M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 23 | 92,800 | $1.9M | $362,982 | 19.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 17 | 9,675 | $967,500 | $320,416 | 33.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 111 | 11,104 | $466,368 | $205,140 | 44.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 15 | 22,680 | $680,400 | $179,996 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 408 | 739 | $249,782 | $65,774 | 26.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 144 | 819 | $200,655 | $43,151 | 21.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 37 | 278 | $120,930 | $25,498 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $55,590 | $11,846 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 97 | $22,601 | $5,397 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 30 | $13,620 | $3,771 | 27.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 48 | $14,910 | $2,793 | 18.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 90 | 90 | $10,980 | $2,606 | 23.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 33 | 63 | $6,924 | $1,440 | 20.8% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 24 | 27 | $5,076 | $1,044 | 20.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 18 | 35 | $3,501 | $780.03 | 22.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 13 | 69 | $3,519 | $759.85 | 21.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 56 | 421 | $2,105 | $343.34 | 16.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,298 | $306.45 | 23.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 13 | 68 | $340.00 | $266.37 | 78.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 69,200 | $1.4M | $309,912 | 22.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 8,150 | $815,000 | $272,555 | 33.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 108 | 10,080 | $423,360 | $170,924 | 40.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 16 | 15,330 | $459,900 | $114,847 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 349 | 603 | $203,814 | $52,833 | 25.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 122 | 553 | $135,485 | $31,101 | 23.0% |
About Dr. Robert Koval, MD
Dr. Robert Koval, MD is a Rheumatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659427334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Koval, MD has received a total of $67,062 in payments from pharmaceutical and medical device companies, with $45,574 received in 2024. These payments were reported across 1,371 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,440).
As a Medicare-enrolled provider, Koval has provided services to 5,131 Medicare beneficiaries, totaling 423,995 services with total Medicare billing of $4.4M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Internal Medicine
- Location Austin, TX
- Active Since 01/26/2007
- Last Updated 02/21/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1659427334
Products in Payments
- SIMPONI ARIA (Biological) $30,632
- RINVOQ (Biological) $6,440
- TREMFYA (Drug) $6,428
- Cimzia (Drug) $2,186
- LUPKYNIS (Drug) $1,308
- Enbrel (Biological) $1,291
- XELJANZ (Drug) $1,191
- TALTZ (Drug) $1,047
- KEVZARA (Drug) $996.99
- ORENCIA (Biological) $937.51
- EVENITY (Biological) $931.96
- KRYSTEXXA (Biological) $715.09
- KEVZARA (Biological) $690.10
- Otezla (Drug) $637.28
- COSENTYX (Biological) $612.11
- SAPHNELO (Biological) $549.27
- BENLYSTA (Biological) $544.34
- SKYRIZI (Biological) $521.42
- ACTHAR (Biological) $508.80
- COSENTYX (Drug) $507.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Austin
Paul Pickrell, Md, MD
Rheumatology — Payments: $29,321
Rheumatology $29,321
Joseph Martinez, Md, MD
Rheumatology — Payments: $21,904
Rheumatology $21,904
Dr. Louis Robinett, M.d, M.D
Rheumatology — Payments: $6,520
Rheumatology $6,520
Marco Lopez Velazquez, M.d, M.D
Rheumatology — Payments: $3,941
Rheumatology $3,941
Sonia Yousuf, Md, MD
Rheumatology — Payments: $2,974
Rheumatology $2,974
Dr. Samir Patel, M.d, M.D
Rheumatology — Payments: $1,565
Rheumatology $1,565